Related Experiment Video
Updated: Jul 22, 2026

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME Study
Gérald Luc1, Dominique Arveiler, Alun Evans
1Department of Atherosclerosis, SERLIA-INSERM UR325, Institut Pasteur de Lille, 1, rue du Professeur Calmette, 59019 Lille, France. gerald.luc@pasteur-lille.fr
Insights
High levels of intercellular adhesion molecule-1 (ICAM-1) predict future heart attacks and coronary death. Combining ICAM-1 and C-reactive protein (CRP) measurements offers a more accurate coronary risk assessment than either marker alone.
Area of Science:
- Cardiovascular Epidemiology
- Biomarker Research
- Preventive Cardiology
Background:
- Cardiovascular diseases remain a leading cause of mortality worldwide.
- Identifying reliable early risk markers for coronary events is crucial for prevention.
- Adhesion molecules like ICAM-1 and VCAM-1 are implicated in atherosclerosis.
Purpose of the Study:
- To investigate the association between plasma levels of soluble intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) and the risk of future coronary events.
- To determine if ICAM-1 and VCAM-1 can serve as independent risk markers for myocardial infarction and angina pectoris.
- To explore the combined predictive value of ICAM-1 and C-reactive protein (CRP) for coronary risk.
Main Methods:
- Prospective cohort study (Epidemiological Study of Myocardial Infarction Study) involving 9758 healthy men aged 50-59.
- Nested case-control design analyzing plasma from 317 coronary event cases and 634 matched controls.
- Measurement of plasma ICAM-1 and VCAM-1 levels at baseline using established laboratory techniques.
Main Results:
- Elevated plasma ICAM-1 levels were significantly associated with an increased risk of myocardial infarction and coronary death (RR: 2.45 without adjustment, RR: 1.90 after CRP adjustment).
- ICAM-1 also showed a significant association with the risk of angina pectoris.
- No significant association was found between plasma VCAM-1 levels and the risk of future acute coronary events or angina pectoris.
- Elevated coronary risk was observed only when both ICAM-1 and CRP levels were high, suggesting a synergistic effect.
Conclusions:
- Plasma ICAM-1 levels are a significant risk marker for future coronary events, regardless of clinical presentation.
- VCAM-1 is not associated with an increased risk of acute coronary events or angina.
- Simultaneous measurement of ICAM-1 and CRP provides a more robust assessment of coronary risk compared to individual markers.
Abstract:
The Epidemiological Study of Myocardial Infarction Study which enrolled 9758 apparently healthy men aged 50-59 years, is a prospective cohort study designed to evaluate markers of coronary risk. Soluble forms of the intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) levels were measured in plasma obtained at baseline from 317 subjects who suffered a coronary event during the 5-year follow-up and in twice the number of control subjects who were matched for center, age and day of inclusion in a nested case-control design. The relative risk associated with the highest compared with the lowest thirds of ICAM-1 (>625 versus <502 ng/ml) was 2.45 (95% CI: 1.64-3.65, P<0.001) without adjustment; it decreased moderately (RR: 2.09; 95% CI: 1.34-3.24, P<0.001) after control for lipid and non-lipid factors and remained significantly elevated after adjustment for C-reactive protein (CRP) (RR: 1.90; 95% CI: 1.21-2.96, P=0.005). Plasma ICAM-1 was essentially associated with the risk of myocardial infarction or coronary death and also with angina pectoris. Subjects with CRP presented elevated coronary risk only if ICAM-1 was high. An elevated level of VCAM-1 was not associated with any risk of future acute coronary event, or with angina pectoris. This data indicates that plasma levels of ICAM-1 may serve as risk markers for future coronary events whatever their clinical presentation and that risk is better defined using simultaneous measurements of ICAM-1 and CRP than any of these levels separately.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Intracellular Signaling Affects Focal Adhesions
Some...
Adherens Junctions
Adherens Junctions are Dynamic
The endothelial cells...
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved in a...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved in a...

